To evaluate the efficacy of a mixture of beta-glucan, inositol and digestive enzymes in improving gastrointestinal symptoms in patients affected by inflammatory bowel disease (IBD)-irritable bowel syndrome (IBS).

Beta-glucan, inositol and digestive enzymes improve quality of life of patients with inflammatory bowel disease and irritable bowel syndrome

Spagnuolo, R
;
Ruggiero, G;Doldo, P
2017-01-01

Abstract

To evaluate the efficacy of a mixture of beta-glucan, inositol and digestive enzymes in improving gastrointestinal symptoms in patients affected by inflammatory bowel disease (IBD)-irritable bowel syndrome (IBS).
2017
Abdominal Pain; Anti-Inflammatory Agents, Non-Steroidal; Biological Factors; Drug Combinations; Drug Therapy, Combination; Female; Flatulence; Gastrointestinal Agents; Humans; Inflammatory Bowel Diseases; Inositol; Irritable Bowel Syndrome; Male; Mesalamine; Middle Aged; beta-Glucans; Enzyme Therapy; Quality of Life
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.12317/63290
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 22
  • ???jsp.display-item.citation.isi??? ND
social impact